Optimizing Resin Performance with Disposable Chromatography Solutions

Publication
Article
BioPharm InternationalBioPharm International-11-15-2014
Volume 2104 eBook
Issue 4

An increased need for higher-capacity resins and the demand for smaller batches has made disposable chromatography a more viable option.

 

Although the initial uptake of single-use chromatography solutions has been relatively slow, an increased need for higher-capacity resins and the demand for smaller batches has made disposable chromatography a more viable option.

 

Download this article

 from BioPharm International’s 2014 Secure Single-Use Systems eBook.

 

 

 

 

 

 

Articles in this issue
BPsupp1114_Innovations_200.jpg
Innovations in Single-Use Bioprocessing Components
BPsupp1114_Langer_200.jpg
Budgets Increase to Support Single-Use Bioprocessing
BPsupp1114_DisposableChromatography_200.jpg
Optimizing Resin Performance with Disposable Chromatography Solutions
BPsupp1114_secrurity_200.jpg
Security of the Single-Use Supply Chain: Is Dual Sourcing the Answer?
BPsupp1114_Single-UseBioreactors200.jpg
Trends in Single-Use Bioreactors
BPsupp1114_Martin_BestPractices_200.jpg
Best Practices for Quality Control and Implementation of Single-Use Systems By Jerold Martin
Recent Videos
Behind the Headlines episode 5
Buy, Sell, Hold: Cell and Gene Therapy
Buy, Sell, Hold: Cell and Gene Therapy
Buy, Sell, Hold: Cell and Gene Therapy
Related Content
Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com

Sanofi Invests €40 Million to Boost Antibody Production in France

Feliza Mirasol
November 21st 2024
Article

The investment will allow Sanofi to strengthen antibody bioproduction at its Lyon Gerland site in France.

Podcast: Alternative Drug Delivery Methods for Biologics: Where Are We At?

Podcast: Alternative Drug Delivery Methods for Biologics: Where Are We At?

Feliza Mirasol
September 27th 2024
Podcast

This podcast explores the challenges of and the progress made so far by the biopharma industry toward alternative drug delivering methods for biologic drugs.

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

BioPharmaSpec Launches Three New R&D Facilities in Europe

Feliza Mirasol
November 20th 2024
Article

The new European facilities located in German, Italy, and Lithuania will specialize in drug discovery and R&D services.

Drug Solutions Podcast: Considering Biologic Drug Development and Manufacturing Holistically

Drug Solutions Podcast: Considering Biologic Drug Development and Manufacturing Holistically

Felicity Thomas
May 25th 2023
Podcast

Hanns-Christian Mahler and Andrea Allmendinger from ten23 health will discuss some key aspects of biologic drug development and manufacturing.

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Alentis Therapeutics Gains $181.4 Million Funding to Advance Anti-Claudin-1 ADCs in Solid Tumors

Feliza Mirasol
November 18th 2024
Article

With financing led by OrbiMed, Novo Holdings, and Jeito Capital, Alentis Therapeutics will develop a pipeline of Claudin-1-targeted ADCs to treat solid tumors.

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Frontier Scientific Solutions to use $1.5 Billion Funds to Establish Global Free Trade Zone Gateway for Life Sciences Supply Chain

Feliza Mirasol
November 15th 2024
Article

Empowered by a $1.5 billion commitment from a major investor, Frontier Scientific Solutions has unveiled its plans for establishing a global free trade zone gateway intended for facilitating the life sciences supply chain using Wilmington International Airport in North Carolina.

© 2024 MJH Life Sciences

All rights reserved.